Matinas BioPharma
MTNB
#10271
Rank
HK$23.75 M
Marketcap
HK$4.67
Share price
-6.14%
Change (1 day)
-95.56%
Change (1 year)

Revenue for Matinas BioPharma (MTNB)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of HK$8.55 Million a decrease over the revenue in the year 2022 that were of HK$24.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Matinas BioPharma from 2013 to 2024

201620192022$5M$10M$15M$20M$25M0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 HK$8.55 M-65.65%
2022 HK$24.91 M9486.35%
2021 HK$0.25 M-78.82%
2020 HK$1.22 M75.48%
2019 HK$0.69 M-25.41%
2018 HK$0.93 M-19.82%
2017 HK$1.16 M
2016 N/A-100%
2015 HK$1.5 M
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA